Lysosomes as targets for cancer therapy

Area of Science:

• Cancer Biology
• Cellular Biology
• Molecular Therapeutics

Background:

• Tumor invasion and metastasis correlate with changes in lysosomal trafficking and elevated cathepsin protease expression.
• Lysosomal alterations may represent a vulnerability in cancer cells, sensitizing them to cell death.
• Lysosomal membrane permeabilization releases cathepsins into the cytosol, triggering cell death pathways.

Purpose of the Study:

• To review recent findings on cancer-associated modifications in lysosome composition and function.
• To explore the therapeutic potential of targeting cancer cell lysosomes.
• To discuss how lysosomal vulnerabilities can be exploited for novel cancer treatments.

Main Methods:

• Review of experimental evidence and recent results.
• Analysis of cancer-related changes in lysosomal pathways.
• Focus on lysosomal membrane permeabilization and cathepsin release.

Main Results:

• Lysosomal alterations are a hallmark of invasive and metastatic cancers.
• Increased cathepsin activity and altered lysosomal function create a potential 'Achilles' heel' for cancer cells.
• Targeting lysosomal pathways shows promise for cancer therapy development.

Conclusions:

• Lysosomes play a critical role in cancer progression and cell death.
• Exploiting lysosomal vulnerabilities offers a promising avenue for novel cancer therapeutics.
• Further research into targeting tumor cell lysosomes is warranted.